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Summary: Many minor components of foods, such as secondary plant metabolites, have been shown 
to posses antioxidant activities, improving the effects of oxidative stress on diabetes and other disease 
conditions. This study evaluates the effect of aqueous extracts from Vernonia amygdalina leaves on 
lipid profiles and oxidative stress in streptozotocin induced diabetic rats. The results showed that the 
streptozotocin induced diabetic rats were subjected to oxidative stress as was shown by the extent of 
lipid peroxidation (high malondialdehyde levels) present in the plasma. The aqueous extract of V. 
amygdalina leaves possessed antioxidant activity as shown by decreases in malondialdehyde levels. 
High values of LDL-cholesterol and triglycerides levels, which are typical of the diabetic condition, 
were also found in streptozotocin induced diabetic rats. The aqueous extract also significantly reduced 
triglyceride levels and normalized cholesterol concentrations. This shows that the aqueous extract of V. 
amygdalina leaves have both hypolipidaemic and antioxidant properties. 
 
 




Diabetes mellitus has been defined by the 
world health organization (WHO), on the basis 
of laboratory findings, as a fasting venous 
plasma glucose concentration greater than 7.8 
mmol/l (140mg/dl) or greater than 11.1 mmol/l 
(200mg/dl) two hours after a carbohydrate 
meal or two hours after an oral ingestion of the 
equivalent of 75g glucose, even if the fasting 
concentration is normal (Nwanjo, 2004). It is a 
metabolic disease characterized by 
hyperglycaemia and glycosuria due to absolute 
or relative lack of insulin (Aguwa, 1996). 
Changes in lipid concentration and 
consequent disorders of lipid metabolism have 
been observed in diabetes mellitus (Ononogbu, 
1988). With Ketosis of diabetes mellitus, 
hyperlipidaemia and hypercholesterolaemia 
may lead to increased level of lipid 
peroxidation. This enhances the oxidation of 
lipids and lipoproteins exposing a diabetic to 
dangers of atherosclerosis (Halliwell, 1990). 
Hence there may be an elevated lipid 
peroxidation in the plasma of diabetic patients. 
Supportive evidence to this approach was the 
finding of increased concentration of plasma 
lipid  
peroxides in diabetic patients with angiopathy 
(Sato and Hotta, 1979), hyperlipidaemic 
patients (Leoper et al, 1983) and patients with 
acute myocardial infarction (Loeper et al, 
1987). 
The non-pharmacological means (diet and 
exercise) and/or the pharmarmacological 
means (insulin and oral hypoglycaemics) may 
be used in the management of diabetes 
mellitus. The obvious limitations of these 
management methods necessitate a search for 
alternatives among the arsenal of herbs 
available to man. It was in this light that the 
World Health Assembly, in 1989, adopted 
among its resolutions, the support of national 
traditional medicine program, drawing 
attention to herbal medicines as being of great 
importance to the health of individuals and 
communities. 
Many minor components of foods, such as 
secondary metabolites, have been shown to 
alter biological processes which many reduce 
the risk of chronic diseases in humans. 
Vernonia amygdalina (compositae) an edible 
rainforest plant native to the south Eastern part 
of Nigeria, has been widely used in folk 
medicine as anti-malaria, purgative, anti-
parasitic, treatment of eczema and for 
maintaining healthy blood glucose levels 
(Nwanjo and Nwokoro, 2004). 
In this study the possible 
hypocholesterolaemic potential and antioxidant 
property of V. amygdalina were investigated 
for its possible use for prophylaxis and 
treatment of atherosclerosis commonly found 
in diabetic diseases. 
 
 




Materials and Method 
Plant Materials 
The fresh leaves of V. amygdalina were 
collected from the natural habitat in Owerri, 
Imo State, Nigeria in January 2005. Botanical 
identity was confirmed by Dr. C. Okeke 
(Head, Department of Plant Science and 
Biotechnology, Imo State University, Owerri). 
A voucher specimen of the plant is deposited 
in Imo State University, Owerri. 
 
Preparation of Extract  
Fresh leaves of V. amygdalina were 
collected and sorted to remove the dead ones, 
washed without squeezing to remove debris 
and dust particles. Large quantities of the 
leaves were collected and sun-dried for four 
days. The dried leaves were milled to get a 
course powder used for the extraction. 25g of 
the powder were macerated in a percolator 
with 250ml of distilled water. The mixture was 
allowed to stand for 24 hours after which it 
was filtered. The filtrate was then placed in an 
oven to evaporate and the solid residue (2.4g) 
referred to as extract. Appropriate 
concentrations of the extract were made in 
distilled water for experiments. 
 
Acute Toxicity Test 
The acute toxicity (LD50) of the extract 
was estimated in 30 Wistar albino rats by the 
I.P. route as described by Miller and Tainter, 
(1944). In brief, the method involved the 
administration of 5 different doses of the 
extract to 5 groups of rats (6 rats/group). The 
number of deaths in each group within 24 
hours was recorded. The LD50 was estimated 
from the graph of percentage (%) mortality 
(converted to probit) against log-dose of the 
extract-probit 5 being 50%. 
 
Phytochemical Tests 
The chemical classes of constituent in the 
freshly prepared extract were detected using 
standard phytochemical reagents and 
procedures as described by Trease and Evans 
(1983).  In general, tests for the presence or 
absence of phytochemical compound using the 
above methods involve the addition of an 
appropriate chemical agent to the crude 
material in a test tube. The mixture is then 
shaken vigorously or gently as the case may 
be. The presence or absence of saponins, 




Adult Wistar albino rats weighing 150-
200g of either sex maintained at room 
temperature of 300C in the animal house of 
College Medicine and Health Sciences, Imo 
State University, Owerri, were used for this 
study. The animals were fed with standard diet 
(product of Pfizer Nigeria Ltd). The food was 
withheld 12 hours before the experiments, but 
there was free access to water. 
 
Experimental Design 
Eighteen rats included for this study were 
divided into 3 groups, each consisting of six 
animals. Out of the 3 groups, 2 were made 
diabetic by intraperitoneal injection of 
65mg/kg body, weight of streptozotocin (STZ) 
(Sigma, St. Louis,  MO, USA) dissolved in 
citrate buffer (0.01M, pH 4.5). Diabetes was 
confirmed by determination of fasting blood 
glucose concentration on the third day post 
administration of STZ showing fasting blood 
glucose levels above 250mg/dl. 
Body weight and fasting blood glucose 
levels of all the rats were determined before 
the start of the experiment. Rats were divided 
into the following groups. 
Group 1: Control given only the citrate buffer 
(0.01M, pH 4.5) 
Group 2: Streptozotocin induced diabetic, 
made with a single dose of streptozotocin 
(65mg/kg body weight) by intraperitoneal 
route. 
Group 3: Diabetic rats treated with V. 
amygdalina 200mg/kg/twice a day, 
Treatment was by oral compulsion. After 14 
days of treatment the body weight and fasting 
blood glucose of the animals were again 
determined. Blood was collected and 
transferred on to a centrifuge tube for serum 
separation. 
 
Analytical Procedure  
Twelve hours after the last treatment and 
after the last food given, 6ml of blood was 
collected from all the rats. The blood collected 
was transferred on to a centrifuge tube and 
allowed for 30min to clot. The clotted blood 
was then centrifuged using Wisperfuge model 
1384 centrifuge (Tamson, Holland) for 5min to 
facilitate separation. The serum thus obtained 
was used for malondialdehyde level MDA 
(product of lipid peroxidation), total 
cholesterol, HDL-cholesterol and triglycerides 
estimations. 
Serum MDA was measured by a 
thiobarbituric acid assay procedure (Albro et 
al, 1986), which was calibrated using 1,1,3,3, - 
tetraethoxypropane (Sigma Chemicals, St. 
Louis, MO, USA.) as a standard. Results were 
expressed as nanomoles of MDA per 
millimeter of serum. Serum total cholesterol 
was estimated using method of Zak (1959), 
plasma triglyceride estimated by method of 




Mendez et al, (1975), HDL-C by Lopez-
Vitrella et al, (1975), LDL-C and VLDL-
triglyceride values were calculated by a 




All values were expressed as mean ± SD. 
The statistical analysis were carried out using 
students’ t-test to detect differences in the 
concentrations of serum MDA and lipoproteins 
between different groups.  Tests with a 




The results of the phytochemical analysis 
revealed the presence of alkaloids, 
carbohydrates, tannins, saponins, flavonoids 
and glycosides. Cyanogenic glycoside was 
however absent. Acute toxicity test in rats gave 
an LD50 of 1265.22± 56mg/kg. From the 
results of the toxicity studies, convenient doses 
were chosen to preclude the lethal range. 
Table I shows that there was a significant 
increase (p<0.05) in fasting blood glucose and 
decrease (p<0.05) in body weight in 
streptozotocin involved diabetic rats when 
compared with the normal control. The body 
weight slightly increased and the fasting blood 
glucose significantly decreased in diabetic rats 
when treated with aqueous leaf extract of 
Vernonia amygdalina.  
In Table 2, the mean value of serum MDA 
levels (end-product of lipid peroxidation) in 
diabetic rat significantly increased when 
compared with the control but significantly 
decreased in diabetic rats treated with the 
aqueous leaf extract of V. amygdalina. 
The mean values of triglycerides and 
LDL-cholesterol (p<0.05) were significantly 
higher in diabetic control rats compared to the 
treated diabetic and normal rats. Total 
cholesterol and HDL-cholesterol levels of 
diabetic rats treated with aqueous extract of V. 
amygdalina leaf were not significantly 
different when compared with the normal 
control rats and diabetic control rats. 
 
Table 1: The mean values of body weight and blood glucose in both normal, diabetic 
         and V. amygdalina treated diabetic rats. Values are expressed as mean ± SD. (n = 6). 
 







Fasting Blood glucose (mg/dl) 
    Initial  After 4 weeks 
 Normal Control 135.4±12.1 171.5±10. 36.1±2.2 84.20±2.8 90.24±3.1 
Diabetic control 137.2±9.9 124.9±13.0 -12.3±2.1* 251.88±4.6 268.24±4.8 
Treated diabetic 
rats 
136.9±10.5 130.1±11.1 -6.8±2.23** 253.82±3.8 128.62±4.6¥ 
 
* Significantly different from normal control group (p<0.05). ** Significantly different from normal 




Table 2: The mean values of lipid peroxide and vitamins E and C in both normal, diabetic and V. 
amygdalina treated diabetic rats. Values are expressed as mean ± SD. (n = 6). 
 
 Normal control Diabetic  control Treated diabetic rats 
MDA (nmol/ml) 3.28±0.26 *5.83±0.49 3.92±04.3 
Total cholesterol 
(mg/dl)  
105.40±0.36 115.0±0.36 101.52 ±1.25 
HDl- cholesterol  
(mg/dl)   
33.25 ± 3.34 30.5±0.70 34.86±0.66 
LDl- cholesterol   
( mg/dl)  
51.45±1.22 **62.32±1.34 *47.76±1.65 
Triglyceride 
(mg/dl) 
91.0±0.36 **110.9±0.69 *94.5±0.43 
 
* Significantly different from normal control group (p<0.05) 
** Significantly different from normal control and treated diabetic rats  (p<0.05) 
 
 






The results of this study clearly indicate 
that the administration of aqueous leaf extract 
of V. amygdalina produced both 
hypoglycaemic, hypolipidaemic and 
antioxidant effect.  There are many bioactive 
constituents present in the extract and hence, at 
present, it is not certain, which of them is/are 
responsible for the observed effects.  However, 
some reports have show that flavonoids, 
tannins and saponins may play some roles in 
antioxidative and hypolipidaemic effect 
(Ezekwe and Obidoa, 2001).  This study 
showed that extract produced a marked 
decrease in blood glucose of diabetic rats. 
These findings had been reported previously in 
our study (Nwanjo and Nwokoro, 2004). 
The increase in serum triglycerides, LDL-
cholesterol and serum MDA in diabetic 
controls are in conformation with pervious 
reports documenting elevated serum 
triglyceride and lipid peroxide levels in 
diabetic subjects (Oberley, 1988). In this study 
administration of aqueous extract of V. 
amygdalina leaf significantly reduced 
triglyceride and suppressed free radical-
induced oxidative damage. 
These hypolipidaemic and lowering of 
oxidative stress may be due to decreased 
oxidative load. It may also act by either 
directly scavenging the reactive oxygen 
metabolites, due to the presence of various 
antioxidant compounds (Gupta et al, 2002), or 
by increasing the synthesis of antioxidant 
molecules. Consistent with the previous report 
that V. amygdalina has hypoglycaemic and 
hypolipidaemic effect, this study has shown 
that it suppresses oxidative stress. This 
warrants further study on the effect of V. 
amygdalina on other diseases that involve free-
radical-induced oxidative damage.  
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